teleo-codex/inbox/queue/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey.md

---
type: source
title: "Oregon's Psilocybin Facilitator Workforce: Survey of First Legal Facilitators and Training Programs"
author: "Journal of Psychoactive Drugs (PMC12304229)"
url: https://pmc.ncbi.nlm.nih.gov/articles/PMC12304229/
date: 2025-01-29
domain: health
secondary_domains: []
format: peer-reviewed
status: unprocessed
priority: high
tags: [psilocybin, Oregon, facilitator-workforce, scalability, access, training, equity]
intake_tier: research-task
---

## Content

**Study design:** Survey of first cohort of Oregon psilocybin facilitator trainees and licensed facilitators. N=106 respondents. Survey conducted 2023, published January 2025.

**Facilitator licensing status at time of survey:**
- Only 16 of 106 (15.1%) had obtained Oregon facilitator license — reflects early-stage program

**Training program landscape:**
- 16 active programs identified with functional websites
- Tuition range: $4,500-$12,000 (mean: $9,359)
- Duration: 80-200 hours coursework + 40-hour practicum; modal program ~120 hours + 40 practicum over ~8 months
- 50% of programs offered scholarships for equity/inclusion
- Financial strain: **79% reported training costs created moderate-to-severe financial strain**

**Facilitator workforce demographics:**
- Race/ethnicity: 64.4% white; 35.6% people of color (more diverse than client population)
- Gender: 40% women, 40% men, 20% other/LGBTQ+
- Education: 72.5% held graduate degrees
- Age: Mean 42.8 years
- Income: 32.5% earned $50,000-$99,999 annually
- Healthcare licenses: 57.3% possessed existing healthcare credentials

**Capacity and practice parameters:**
- Mean intended weekly service hours: 18.6 hours
- Intended monthly clients: approximately 10 per facilitator
- Mean planned session cost: $1,388 per session (below current market of $1,500-3,000)
- Specialization interests: Trauma (83%), mental health disorders (69%), consciousness exploration (68%)

**Scalability calculation (derived):**
- At 10 clients/month, each licensed facilitator can serve ~120 clients/year
- Oregon had ~500 licensed facilitators as of Q1 2026 → ~60,000 clients/year Oregon capacity
- Oregon's Q1 2025 rate: 1,509 clients in 4 months → ~4,500/year Oregon run rate
- Oregon is at ~7.5% of theoretical facilitator capacity — not a capacity constraint yet at current demand
- But US-level TRD population is 7 million → scaling nationally requires orders-of-magnitude more facilitators

**Structural bottleneck analysis:**
- Training costs ($9,359 mean) + 160 hours minimum + $2,000/year licensing + $10,000+ regulatory fees for service centers
- $12,000 liability insurance per facilitator opening a center
- Equity concern: high training costs filter toward already-credentialed healthcare workers

## Agent Notes
**Why this matters:** This is the first empirical data on the facilitator pipeline that will determine whether psilocybin therapy can scale beyond the current high-income, urban, white user base. The key finding: facilitators are diverse (35.6% POC — more than clients), but the training cost barrier ($9,359 mean with 79% reporting moderate-to-severe financial strain) filters toward people who already have financial resources and healthcare credentials.

**What surprised me:** The Oregon capacity utilization figure: Oregon has ~500 facilitators with capacity for ~60,000 clients/year, but is only serving ~4,500/year. This means Oregon's psilocybin access gap is NOT primarily a supply-side capacity problem — it's a demand-side cost and coverage problem. The facilitators are there; people can't afford the sessions.

**What I expected but didn't find:** Evidence that capacity constraints are limiting access. The problem is cost/affordability, not facilitator availability. This inverts the typical healthcare access story (where supply — doctors, clinics — is the constraint).

**KB connections:**
- [[the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access]] — Oregon's psilocybin program has facilitator supply but cost/coverage demand failure
- [[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]] — similar structural gap: evidence + provider capacity + infrastructure exists, but operational integration absent

**Extraction hints:**
- New claim: "Oregon's psilocybin access gap is a demand-side cost failure, not a supply-side capacity problem — facilitators have capacity for 60,000 clients/year but only 4,500/year are being served because session costs ($1,200-3,000) are uninsured and out-of-pocket"
- The 79% facilitator financial strain during training is itself a claim candidate: it filters toward economically privileged trainees despite the program's equity intentions
- The 35.6% facilitator POC representation (vs. 12.5% client POC representation) creates an ironic inversion: the workforce is more diverse than the clientele it serves

**Context:** Journal of Psychoactive Drugs — established, peer-reviewed journal for substance use and psychedelic research. Published January 2025. Survey represents Oregon's first cohort of facilitators during 2023, so reflects early-stage program status. Current facilitator count (~500 as of 2026) exceeds the 16/106 licensed at survey time.

## Curator Notes (structured handoff for extractor)
PRIMARY CONNECTION: [[the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access]]
WHY ARCHIVED: Provides the most rigorous data available on the psilocybin facilitator pipeline — both its demographics and its scalability constraints. The demand-side vs. supply-side diagnosis (capacity exists, cost is the barrier) is analytically important and potentially counter-intuitive.
EXTRACTION HINT: The key insight is the INVERSION from typical healthcare access analysis. Oregon is not supply-constrained for psilocybin services — it is cost-constrained on the demand side. This matters for policy: the solution is reimbursement, not more facilitator training programs. Extract this as the primary claim. Secondary: the facilitator financial strain finding as evidence that the training pipeline itself has equity issues.